交易中 10-15 11:05:58 美东时间
+0.090
+0.66%
今日重点评级关注:DA Davidson:维持美光科技"买入"评级,目标价从2100美元升至3000美元;Leerink Partners:维持OmniAb"跑赢大市"评级,目标价从10美元升至12美元
10-08 12:30
Macquarie analyst Chad Beynon maintains Ballys (NYSE:BALY) with a Neutral and raises the price target from $11 to $12.
10-07 23:48
Las Vegas is on the tail end of a rare citywide five-day sale that ran this week. The Vegas 5-Day sale sees resorts cut prices on rooms, dining, entertainment, and attractions as the industry looks to...
09-26 01:27
U.S. stocks were lower, with the Nasdaq Composite falling over 150 points on Thursday. Shares of Everpure, Inc. (NYSE:P) rose sharply after the data storage company outlined a broader growth strategy and issued a preliminary fiscal 2028 outlook at its 2026 Financial Analyst Meeting. The company also...
09-24 22:01
Bally’s Corporation (BALY) secured $560M in new financing led by WhiteHawk Capital Partners to fund further development of its Bally’s Bronx project and for general corporate purposes. The financing i...
09-14 19:24
Gainers American Outdoor Brands (NASDAQ:AOUT) stock moved upwards by 41.7% to $14.19 during Friday's regular session. The market value of their outstanding shares is at $126.3 million. As per the news, the Q1 earnings report came out yesterday. GoPro (NASDAQ:GPRO) stock increased by 33.72% to $1.86....
09-05 01:06
Bally’s Corp (BALY) chief financial officer Mira Mircheva is resigning, effective Sept. 4, 2026. Mircheva will remain with Bally’s through Sept. 30, 2026, to support a smooth leadership transition. Pr...
09-04 04:28
Bally's Corporation (NYSE:BALY) announced today that Executive Vice President and Chief Financial Officer, Mira Mircheva, has notified the Company of her intent to resign her positions of Executive Vice President and Chief Financial Officer. Ms. Mircheva is leaving Bally’s for personal reasons and w...
09-04 04:16
今日重点评级关注:摩根士丹利:维持Ultragenyx Pharmaceutical"超配"评级,目标价从67美元升至74美元;Truist Securities:维持Solid Biosciences"买入"评级,目标价从16美元升至20美元
08-24 16:40
今日重点评级关注:Ascendiant Capital:维持Alzamend Neuro"买入"评级,目标价从25美元升至26美元;Tigress Financial:维持Legence"买入"评级,目标价从125美元升至130美元
08-20 08:39